Kurzfassung

A randomized, double-blind, vehicle-controlled, multicenter, parallel
group study to assess the efficacy, safety, and tolerability of topical
terbinafine hydrogen chloride (HCl) formulation for 24 or 48 weeks
of treatment in patients with mild to moderate toenail onychomycosis
(CSFO327N2302)